Patent · US Active

Recombinant baculovirus and method for using the same for preparing recombinant adeno-associated virus vector

US10501758B2 · kind B2 · utility

2Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2018
Grant dateDec 10, 2019
Priority date
Expiry dateJan 31, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A recombinant baculovirus, including: an adeno-associated virus Rep gene, an adeno-associated virus Cap gene, and an recombinant adeno-associated virus genome ITR-GOI (gene of interest) flanked by rAAV inverted terminal repeats (ITR). The ITR-GOI includes a 5′ terminal nucleic acid fragment and a 3′ terminal nucleic acid fragment. The ITR-GOI is linked to an expression cassette of the Cap gene and an expression cassette of the Rep gene through the 5′ terminal nucleic acid fragment and the 3′ terminal nucleic acid fragment, respectively.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.